Arcturus Therapeutics Holdings (ARCT) Non-cash Items (2019 - 2025)

Arcturus Therapeutics Holdings has reported Non-cash Items for 7 years, with the latest figure at $13.3 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 44.19% year-over-year to $13.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (up 44.19% YoY), and the FY2025 full-year result was $13.3 million, up 167.56% from the prior year.
• Non-cash Items for Q4 2025 stood at $13.3 million, up from $9.2 million in the prior quarter.
• The five-year high for Non-cash Items was $53.3 million in Q4 2023, with the low at $9.2 million in Q4 2024.
• Historically, Non-cash Items has averaged $26.7 million across 5 years, with a median of $13.3 million in 2025.
• Annual changes were most pronounced in 2021 — Non-cash Items soared 6458.67% — and 2024, when it plunged 82.65%.
• Arcturus Therapeutics Holdings' Non-cash Items stood at $47.1 million in 2021, then sank by 77.24% to $10.7 million in 2022, then surged by 397.11% to $53.3 million in 2023, then sank by 82.65% to $9.2 million in 2024, then soared by 44.19% to $13.3 million in 2025.
• The last three Non-cash Items figures came in at $13.3 million (Q4 2025), $9.2 million (Q4 2024), and $53.3 million (Q4 2023), per Business Quant data.